1. G. Wilhelmi,Ueber die pharmakologischen Eigenschaften von Irgapyrin, einen neuen Präparat aus der Pyrazolreihe, Schweiz. Med. Wochenschr.79, 577–282 (1949).
2. C.V. Winder, V. Wax, M. Burr, M. Been andC.E. Rosiere,A study of pharmacological influences on ultraviolet erythema in guinea pigs, Arch. Int. Pharmacodyn.116, 261–292 (1958).
3. S.S. Adams andR. Cobb, The effect of salicylates and related compounds on erythema in the guinea-pig and man. InSalicylates: An International Symposium pp. 127–140. (Ed.A.S.J. Dixon, B.K. Martin, M.J.H. Smith andP.H.N. Wood), Little, Brown and Co., Boston 1963.
4. J.R. Vane,Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature (New Biol.)231, 232–235 (1971).
5. R. Flower, R. Gryglewski, K. Herbaczynska-Cedro andJ.R. Vane,Effects of anti-inflammatory drugs on prostaglandin biosynthesis, Nature (New Biol.)238, 104–106 (1972).